CJ's Bio Pharma business covers such products as nucleic acids, lysine, over-the-couter medicines and prescription medicines. Our bio-sector business began in 1964 with the production of Monosodium Glutamate (MSG) using what were then the most modern fermentation and refining technologies. Since then, we have established production facilities for animal feed additives in Indonesia, China and Brasil, from which we produce Lysine, Threonine and the nucleic acids IMP, GMP and I&G for local use and export to the US and Europe. We entered the pharmaceutical business in 1984, and have since grown into one of the leading drug manufacturers in Korea. With our top-notch R&D capabilities we successfully developed the hepatitis B vaccine "Hepaccine". We also recently acquired Hanil Pharmaceutical Company, whose intellectual property portfolio includes the original drug manufacturing and marketing rights for such drugs as Mevalotin, Banan, and Herben.